• Facebook
  • Twitter
  • LinkedIn
  • Google +
  • RSS

Aridis Pharmaceuticals - Articles and news items


Aridis expands Phase 2a trial of AR-301 into the US

Industry news / 9 July 2015 / Victoria White

The US Food and Drug Administration (FDA) has accepted Aridis Pharmaceuticals’ Investigational New Drug (IND) application for AR-301 (Salvecin)…


Win an Amazon Gift Card worth up to €100!TAKE OUR SURVEY
+ +